30% off. Use code SUMMER30 at checkout for 30% off for 12 months on Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Novadel Pharma Inc (NVDL)

Track

Stock chart
Ticker: NVDL Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Moorin Jay
1 purchase — total 800,000 USD
Buy 31 Mar 2010
Value US$466,217.80 | Price 289.24 | Shares 58,607
Buy 11 Dec 2009
Value US$3,647,889.85 | Price 338.43 | Shares 40,176
Buy 11 Dec 2009
Value US$3,263,330.03 | Price 406.97 | Shares 88,041
Buy 11 Dec 2009
Value US$81,701.32 | Price 0.18 | Shares 465,800
Buy 8 Dec 2009
Value US$35,325.65 | Price 0.15 | Shares 236,134
Buy 8 Dec 2009
Value US$37,178.72 | Price 0.14 | Shares 263,866
Buy 30 Aug 2007
Value US$3,200.00 | Price 0.80 | Shares 4,000
Buy 30 Aug 2007
Value US$4,187.00 | Price 0.79 | Shares 5,300
Buy 29 Aug 2007
Value US$3,920.00 | Price 0.80 | Shares 4,900
Buy 28 Aug 2007
Value US$3,332.00 | Price 0.68 | Shares 4,900
Buy 28 Aug 2007
Value US$68.00 | Price 0.68 | Shares 100
Buy 28 Aug 2007
Value US$1,686.30 | Price 0.73 | Shares 2,310
Buy 28 Aug 2007
Value US$2,627.64 | Price 0.73 | Shares 3,600
Buy 28 Aug 2007
Value US$69.00 | Price 0.69 | Shares 100
Buy 27 Aug 2007
Value US$10,200.00 | Price 0.68 | Shares 15,000
Buy 24 Aug 2007
Value US$26,044.00 | Price 0.65 | Shares 40,000
Buy 24 Aug 2007
Value US$4,095.00 | Price 0.65 | Shares 6,300
Buy 23 Aug 2007
Value US$25,545.00 | Price 0.65 | Shares 39,300
Buy 22 Aug 2007
Value US$2,830.08 | Price 0.64 | Shares 4,400
Buy 21 Aug 2007
Value US$30,350.00 | Price 0.61 | Shares 50,000
Buy 20 Aug 2007
Value US$14,784.00 | Price 0.66 | Shares 22,400
Buy 20 Aug 2007
Value US$2,240.00 | Price 0.64 | Shares 3,500
Buy 20 Aug 2007
Value US$2,583.00 | Price 0.63 | Shares 4,100
Buy 20 Aug 2007
Value US$14,925.00 | Price 0.60 | Shares 25,000
Buy 5 Jan 2007
Value US$1,107,001.05 | Price 1.45 | Shares 763,449
Buy 5 Jan 2007
Value US$1,394,775.30 | Price 1.45 | Shares 961,914
Buy 30 Jun 2006
Value US$25,740.00 | Price 1.32 | Shares 19,500
Buy 23 Jun 2006
Value US$2,070.00 | Price 1.38 | Shares 1,500
Buy 19 Apr 2006
Value US$50,000.68 | Price 1.58 | Shares 31,646
Buy 19 Apr 2006
Value US$203,962.20 | Price 1.58 | Shares 129,090
Buy 12 Apr 2006
Value US$1,000,001.20 | Price 1.45 | Shares 689,656
Buy 29 Dec 2005
Value US$5,900.00 | Price 1.18 | Shares 5,000
Buy 30 Jun 2005
Value US$3,000.00 | Price 1.20 | Shares 2,500
Buy 29 Jun 2005
Value US$9,225.00 | Price 1.23 | Shares 7,500
Buy 29 Jun 2005
Value US$20,130.00 | Price 1.22 | Shares 16,500
Buy 29 Jun 2005
Value US$1,210.00 | Price 1.21 | Shares 1,000
Buy 28 Jun 2005
Value US$1,220.00 | Price 1.22 | Shares 1,000
Buy 23 Dec 2004
Value US$33,635.00 | Price 1.55 | Shares 21,700
Buy 22 Dec 2004
Value US$27,450.00 | Price 1.50 | Shares 18,300
Buy 22 Dec 2004
Value US$12,814.00 | Price 1.49 | Shares 8,600
Buy 22 Dec 2004
Value US$2,072.00 | Price 1.48 | Shares 1,400
Buy 22 Dec 2004
Value US$7,350.00 | Price 1.47 | Shares 5,000
Planned sale 2 Jul 2004
Value US$14,630.00 | Price 1.90 | Shares 7,700
Planned sale 1 Jul 2004
Value US$14,784.00 | Price 1.92 | Shares 7,700
Planned sale 30 Jun 2004
Value US$15,400.00 | Price 2.00 | Shares 7,700
Planned sale 29 Jun 2004
Value US$14,630.00 | Price 1.90 | Shares 7,700
Planned sale 28 Jun 2004
Value US$14,630.00 | Price 1.90 | Shares 7,700
Sale 24 Jun 2004
Value US$8,500.00 | Price 1.70 | Shares 5,000
Sale 24 Jun 2004
Value US$8,700.00 | Price 1.74 | Shares 5,000
Sale 24 Jun 2004
Value US$17,500.00 | Price 1.75 | Shares 10,000
Buy 31 Mar 2004
Value US$7,950.00 | Price 1.59 | Shares 5,000
Buy 30 Mar 2004
Value US$4,980.00 | Price 1.66 | Shares 3,000
Buy 29 Mar 2004
Value US$4,920.00 | Price 1.64 | Shares 3,000
Buy 8 Jan 2004
Value US$21,214.20 | Price 1.05 | Shares 20,204
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2010-04-01 2010-03-31 B Purchase Moorin Jay Large shareholder
58,607 +10.8%
289.24
US$466,218 		58,607 +10.8% 289.24 US$466,218
2009-12-14 2009-12-11 B Purchase RATOFF STEVEN B

Chief Executive Officer

Executive Director
40,176 -26.1%
338.43
US$3,647,890 		40,176 -26.1% 338.43 US$3,647,890
2009-12-14 2009-12-11 B Purchase RATOFF STEVEN B

Chief Executive Officer

Executive Director
88,041 -36.0%
406.97
US$3,263,330 		88,041 -36.0% 406.97 US$3,263,330
2009-12-14 2009-12-11 B Purchase RATOFF STEVEN B

Chief Executive Officer

Executive Director
465,800 +43.9%
0.18
US$81,701 		465,800 +43.9% 0.18 US$81,701
2009-12-14 2009-12-08 B Purchase RATOFF STEVEN B

Chief Executive Officer

Executive Director
236,134 +28.7%
0.15
US$35,326 		236,134 +28.7% 0.15 US$35,326
2009-12-14 2009-12-08 B Purchase RATOFF STEVEN B

Chief Executive Officer

Executive Director
263,866 +47.1%
0.14
US$37,179 		263,866 +47.1% 0.14 US$37,179
2007-09-04 2007-08-30 B Purchase HAMILTON WILLIAM F PHD Non-Executive Director
4,000 +80.0%
0.80
US$3,200 		4,000 +80.0% 0.80 US$3,200
2007-08-31 2007-08-30 B Purchase Bonney Thomas E Non-Executive Director
5,300 +26.5%
0.79
US$4,187 		5,300 +26.5% 0.79 US$4,187
2007-08-29 2007-08-29 B Purchase Baric Mark J Non-Executive Director
4,900 +4900.0%
0.80
US$3,920 		4,900 +4900.0% 0.80 US$3,920
2007-09-04 2007-08-28 B Purchase HAMILTON WILLIAM F PHD Non-Executive Director
4,900 +4900.0%
0.68
US$3,332 		4,900 +4900.0% 0.68 US$3,332
2007-09-04 2007-08-28 B Purchase HAMILTON WILLIAM F PHD Non-Executive Director
100 +inf%
0.68
US$68 		100 +inf% 0.68 US$68
2007-08-29 2007-08-28 B Purchase RATOFF STEVEN B Non-Executive Director
2,310 +0.9%
0.73
US$1,686 		2,310 +0.9% 0.73 US$1,686
2007-08-29 2007-08-28 B Purchase RATOFF STEVEN B Non-Executive Director
3,600 +1.4%
0.73
US$2,628 		3,600 +1.4% 0.73 US$2,628
2007-08-29 2007-08-28 B Purchase Baric Mark J Non-Executive Director
100 +inf%
0.69
US$69 		100 +inf% 0.69 US$69
2007-08-28 2007-08-27 B Purchase Nemeroff Charles Non-Executive Director
15,000 +inf%
0.68
US$10,200 		15,000 +inf% 0.68 US$10,200
2007-08-28 2007-08-24 B Purchase Bergstrom David H

SVP & Chief Operating Officer

Officer
40,000 +inf%
0.65
US$26,044 		40,000 +inf% 0.65 US$26,044
2007-08-27 2007-08-24 B Purchase RATOFF STEVEN B Non-Executive Director
6,300 +2.5%
0.65
US$4,095 		6,300 +2.5% 0.65 US$4,095
2007-08-24 2007-08-23 B Purchase RATOFF STEVEN B Non-Executive Director
39,300 +18.8%
0.65
US$25,545 		39,300 +18.8% 0.65 US$25,545
2007-08-23 2007-08-22 B Purchase RATOFF STEVEN B Non-Executive Director
4,400 +2.2%
0.64
US$2,830 		4,400 +2.2% 0.64 US$2,830
2007-08-22 2007-08-21 B Purchase RATOFF STEVEN B Non-Executive Director
50,000 +32.4%
0.61
US$30,350 		50,000 +32.4% 0.61 US$30,350
2007-08-21 2007-08-20 B Purchase SPICER MICHAEL E B

CFO and Corporate Secretary

Officer
22,400 +134.9%
0.66
US$14,784 		22,400 +134.9% 0.66 US$14,784
2007-08-21 2007-08-20 B Purchase SPICER MICHAEL E B

CFO and Corporate Secretary

Officer
3,500 +26.7%
0.64
US$2,240 		3,500 +26.7% 0.64 US$2,240
2007-08-21 2007-08-20 B Purchase RATOFF STEVEN B Non-Executive Director
25,000 +19.4%
0.60
US$14,925 		25,000 +19.4% 0.60 US$14,925
2007-08-21 2007-08-20 B Purchase SPICER MICHAEL E B

CFO and Corporate Secretary

Officer
4,100 +45.6%
0.63
US$2,583 		4,100 +45.6% 0.63 US$2,583
2007-01-26 2007-01-05 B Purchase ProQuest Investments III, L.P. Large shareholder
763,449 +18.1%
1.45
US$1,107,001 		763,449 +18.1% 1.45 US$1,107,001
2007-01-26 2007-01-05 B Purchase Moorin Jay Large shareholder
961,914 +18.1%
1.45
US$1,394,775 		961,914 +18.1% 1.45 US$1,394,775
2006-07-05 2006-06-30 B Purchase Bonney Thomas E Non-Executive Director
19,500 +inf%
1.32
US$25,740 		19,500 +inf% 1.32 US$25,740
2006-06-27 2006-06-23 B Purchase SPICER MICHAEL E B

Chief Financial Officer

Officer
1,500 +20.0%
1.38
US$2,070 		1,500 +20.0% 1.38 US$2,070
2006-04-21 2006-04-19 B Purchase LOBELL J JAY Non-Executive Director
31,646 +21.7%
1.58
US$50,001 		31,646 +21.7% 1.58 US$50,001
2006-04-21 2006-04-19 B Purchase RATOFF STEVEN B Non-Executive Director
129,090 +inf%
1.58
US$203,962 		129,090 +inf% 1.58 US$203,962
2006-04-14 2006-04-12 B Purchase Moorin Jay Large shareholder
689,656 +14.9%
1.45
US$1,000,001 		689,656 +14.9% 1.45 US$1,000,001
2006-01-03 2005-12-29 B Purchase SPICER MICHAEL E B

Chief Financial Officer

Officer
5,000 +200.0%
1.18
US$5,900 		5,000 +200.0% 1.18 US$5,900
2005-07-01 2005-06-30 B Purchase SPICER MICHAEL E B

Chief Financial Officer

Officer
2,500 +inf%
1.20
US$3,000 		2,500 +inf% 1.20 US$3,000
2005-06-30 2005-06-29 B Purchase Shangold Gary A

President & CEO

Executive Director
7,500 +10.9%
1.23
US$9,225 		7,500 +10.9% 1.23 US$9,225
2005-06-30 2005-06-29 B Purchase Shangold Gary A

President & CEO

Executive Director
16,500 +31.7%
1.22
US$20,130 		16,500 +31.7% 1.22 US$20,130
2005-06-30 2005-06-29 B Purchase Shangold Gary A

President & CEO

Executive Director
1,000 +2.0%
1.21
US$1,210 		1,000 +2.0% 1.21 US$1,210
2005-06-30 2005-06-28 B Purchase Shangold Gary A

President & CEO

Executive Director
1,000 +2.0%
1.22
US$1,220 		1,000 +2.0% 1.22 US$1,220
2004-12-23 2004-12-23 B Purchase Shangold Gary A

President & CEO

Officer
21,700 +76.7%
1.55
US$33,635 		21,700 +76.7% 1.55 US$33,635
2004-12-23 2004-12-22 B Purchase Shangold Gary A

President & CEO

Officer
18,300 +183.0%
1.50
US$27,450 		18,300 +183.0% 1.50 US$27,450
2004-12-23 2004-12-22 B Purchase Shangold Gary A

President & CEO

Officer
8,600 +614.3%
1.49
US$12,814 		8,600 +614.3% 1.49 US$12,814
2004-12-23 2004-12-22 B Purchase Shangold Gary A

President & CEO

Officer
1,400 +inf%
1.48
US$2,072 		1,400 +inf% 1.48 US$2,072
2004-12-22 2004-12-22 B Purchase Cohen Barry

VP, Product & Business Dev

Officer
5,000 +inf%
1.47
US$7,350 		5,000 +inf% 1.47 US$7,350
2004-07-06 2004-07-02 PlS Planned sale
DUGGER HARRY A III PH D

Chief Scientific Officer
7,700 -0.7%
1.90
US$14,630 		7,700 -0.7% 1.90 US$14,630
2004-07-06 2004-07-01 PlS Planned sale
DUGGER HARRY A III PH D

Chief Scientific Officer
7,700 -0.7%
1.92
US$14,784 		7,700 -0.7% 1.92 US$14,784
2004-06-30 2004-06-30 PlS Planned sale DUGGER HARRY A III PH D

Chief Scientific Officer
7,700 -0.7%
2.00
US$15,400 		7,700 -0.7% 2.00 US$15,400
2004-06-30 2004-06-29 PlS Planned sale DUGGER HARRY A III PH D

Chief Scientific Officer
7,700 -0.7%
1.90
US$14,630 		7,700 -0.7% 1.90 US$14,630
2004-06-30 2004-06-28 PlS Planned sale DUGGER HARRY A III PH D

Chief Scientific Officer
7,700 -0.7%
1.90
US$14,630 		7,700 -0.7% 1.90 US$14,630
2004-06-28 2004-06-24 S Sale SCHAUL ROBERT F Non-Executive Director
5,000 -20.6%
1.70
US$8,500 		5,000 -20.6% 1.70 US$8,500
2004-06-28 2004-06-24 S Sale SCHAUL ROBERT F Non-Executive Director
5,000 -17.1%
1.74
US$8,700 		5,000 -17.1% 1.74 US$8,700
2004-06-28 2004-06-24 S Sale SCHAUL ROBERT F Non-Executive Director
10,000 -25.5%
1.75
US$17,500 		10,000 -25.5% 1.75 US$17,500
2004-04-01 2004-03-31 B Purchase ROSENWALD LINDSAY A MD Large shareholder
5,000 +0.1%
1.59
US$7,950 		5,000 +0.1% 1.59 US$7,950
2004-03-31 2004-03-30 B Purchase ROSENWALD LINDSAY A MD Large shareholder
3,000 +0.1%
1.66
US$4,980 		3,000 +0.1% 1.66 US$4,980
2004-03-30 2004-03-29 B Purchase ROSENWALD LINDSAY A MD Large shareholder
3,000 +0.1%
1.64
US$4,920 		3,000 +0.1% 1.64 US$4,920
2004-01-12 2004-01-08 B Purchase KESSEL LARRY Non-Executive Director
20,204 +inf%
1.05
US$21,214 		20,204 +inf% 1.05 US$21,214
Explore more

More insider trading research around Novadel Pharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America